1. Home
  2. DGII vs HAE Comparison

DGII vs HAE Comparison

Compare DGII & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$65.70

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$71.16

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGII
HAE
Founded
1985
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
DGII
HAE
Price
$65.70
$71.16
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$48.80
$84.13
AVG Volume (30 Days)
339.9K
918.3K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
77.05
N/A
EPS
0.60
2.05
Revenue
$430,221,000.00
$910,373,000.00
Revenue This Year
$18.71
N/A
Revenue Next Year
$7.22
$5.23
P/E Ratio
$115.42
$34.07
Revenue Growth
1.46
N/A
52 Week Low
$30.69
$47.32
52 Week High
$70.79
$87.32

Technical Indicators

Market Signals
Indicator
DGII
HAE
Relative Strength Index (RSI) 55.00 72.12
Support Level $60.44 $48.98
Resistance Level $69.81 $86.72
Average True Range (ATR) 2.54 2.53
MACD -0.16 0.87
Stochastic Oscillator 52.85 94.85

Price Performance

Historical Comparison
DGII
HAE

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: